Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its boronic acid functional group enables participation in Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds during the construction of complex drug molecules. Commonly employed in medicinal chemistry for late-stage functionalization, it helps optimize biological activity and pharmacokinetic properties in drug candidates.